Kengo Ebina

Title: Kengo Ebina: Innovator in Pharmaceutical Chemistry

Introduction

Kengo Ebina is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of anti-ulcer agents. With a total of 2 patents, his work has had a meaningful impact on therapeutic applications.

Latest Patents

Ebina's latest patents include the invention of an enantiomer of tenatoprazole and its use in therapy. This invention relates to optically active substances of tenatoprazole, specifically the compounds (+) and (−)-5-methoxy-2-{(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl}-1H-imidazo[4,5-b]pyridine. These compounds and their pharmaceutical compositions are recognized for their utility as anti-ulcer agents.

Career Highlights

Throughout his career, Kengo Ebina has worked with prominent companies in the pharmaceutical industry. He has been associated with Mitsubishi Pharma Corporation and Mitsubishi Tanabe Pharma Corporation, where he has contributed to various innovative projects.

Collaborations

Ebina has collaborated with notable professionals in his field, including Setsuo Yamashita. Their joint efforts have further advanced the research and development of pharmaceutical solutions.

Conclusion

Kengo Ebina's contributions to pharmaceutical chemistry, particularly through his patents and collaborations, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.